Skip to content
healthcare.dev

berkley and jensen clearlax

NDC 68391-306, Polyethylene Glycol 3350, powder, for solution, from BJWC.

Product NDC
68391-306
Status
Listed
Labeler
BJWC
Dosage form
POWDER, FOR SOLUTION
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA090685
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68391-306 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • POLYETHYLENE GLYCOL 335017 g/17g

Pharmacologic classes

Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

Package NDCNDC-11Package
68391-306-0268391030602765 g in 1 BOTTLE (68391-306-02)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 68391-306 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68391-306 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68391-306. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.